A booster shot of the Pfizer COVID-19 vaccine increases immunity in children 5 to 11, and some types of cancer patients are at higher risk of breakthrough COVID-19.
is rounding up some of the most notable coronavirus news making headlines online. Here’s what you need to know for Friday, April 15.A booster shot of the Pfizer-BioNTech COVID-19 vaccine increases immunity in children 5 to 11, particularly against the omicron variant, the companiesPfizer and BioNTech intend to request authorization soon from the Food and Drug Administration for a booster for 5-to-11-year-olds, news reports said., just before the omicron variant emerged.
Still, these rates were all significantly higher than the breakthrough infection rates in the non-cancer population, the researchers found.45,253 patients with the 12 most common cancers in the United States, including bladder, breast, colorectal, kidney, liver, lung, pancreatic, prostate and thyroid.
When the olfactory bulb tissues were compared, the patients with COVID-19 had fewer nerve fibers in their olfactory bulbs, researchers said in a news release. This didn’t change when the findings were adjusted for impact of aging.American high school students’ mental health suffered in pandemic, CDC study suggests
In 2021, 12% of female students, more than 25% of LGB students, and 17% of students questioning their sexuality attempted suicide during the past year compared to 5% of their male peers and 5% of their heterosexual peers, respectively.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer to seek COVID-19 booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Baca lebih lajut »
Pfizer Says Covid-19 Booster in Children Ages 5 to 11 Sparked Immune Response Against OmicronA booster shot of the Pfizer-BioNTech Covid vaccine in children ages 5 to 11 significantly increased antibody levels against the Omicron variant as well as against the initial strain it was designed to fight, a late-stage study found.
Baca lebih lajut »
COVID-19 booster: Pfizer to seek extra shot for healthy kids 5 to 11Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.
Baca lebih lajut »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNEW: Pfizer says it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Baca lebih lajut »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy children ages 5-11.
Baca lebih lajut »